PRALSETINIB

1661 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking PRALSETINIB:

# Side effect Count
0 DEATH 137
1 PRODUCT PRESCRIBING ISSUE 130
2 FATIGUE 122
3 ASTHENIA 112
4 OFF LABEL USE 111
5 HYPERTENSION 95
6 ANAEMIA 91
7 DISEASE PROGRESSION 88
8 DIARRHOEA 87
9 BLOOD PRESSURE INCREASED 83
See all common reactions for PRALSETINIB

PRALSETINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALK GENE REARRANGEMENT POSITIVE 1 0.1429
1 CYTOKERATIN 19 INCREASED 1 0.1000
2 GRANULOCYTE-COLONY STIMULATING FACTOR LEVEL DECREASED 1 0.0909
3 RET GENE MUTATION 2 0.0690
4 BLOOD CALCITONIN DECREASED 1 0.0526
5 BLOOD CALCITONIN INCREASED 6 0.0400
6 DEFORMITY OF ORBIT 1 0.0333
7 MORAXELLA TEST POSITIVE 1 0.0263
8 SUBCAPSULAR HEPATIC HAEMATOMA 1 0.0227
9 UVEAL MELANOMA 1 0.0196
See all enriched reactions for PRALSETINIB